Guardant Health Inc, a leading precision oncology company, announced that results from the ECLIPSE study showing the effectiveness of its ShieldTM blood test for detecting colorectal cancer (CRC) in average-risk adults will be published in the March 14 issue of The New England Journal of Medicine.
Medline, a market-leading manufacturer and supplier of medical supplies and solutions, announced the successful acquisition of the manufacturing rights and intellectual property of AG Cuffill from Hospitech Respiration Ltd. The compact and intuitive syringe-like device provides an accurate solution for measuring both pressure and volume of airway cuffs in all clinical settings.
Bruker Corporation is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions.
Clear Guide Medical proudly announces the FDA clearance for the CLEAR GUIDE SCENERGY computer aided instrument guidance system, alongside the new TP Access Tool with SteriGRID™.
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced that Rhinology Journal has published positive two-year outcomes from the VATRAC trial.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced Dovato (dolutegravir/ lamivudine) is now available in a blister pack in the U.S.
Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).
PrepMD, the leading cardiac healthcare solutions provider, announced the accreditation of their online healthcare training programs for Nursing Continuing Education Units (CEUs).
Accuray Incorporated announced that the Providence Swedish Radiosurgery Center in Seattle, Washington is enhancing its cancer treatment capabilities with the purchase of the latest generation CyberKnife® S7™ System, the hospital's second CyberKnife radiation delivery device purchase.
Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced full market availability of its new ESG-410™ Surgical Energy Platform for conventional monopolar and bipolar, advanced energy applications now including ultrasonic dissection and hybrid energy.